Cytarabine dose for acute myeloid leukemia

N Engl J Med. 2011 Jun 2;364(22):2167-8; author reply 2168-9. doi: 10.1056/NEJMc1104343.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aged
  • Antimetabolites, Antineoplastic / administration & dosage*
  • Cytarabine / administration & dosage*
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / genetics
  • Leukemia, Myeloid, Acute / mortality
  • Middle Aged
  • Monosomy
  • Regression Analysis
  • Survival Analysis
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Cytarabine